
A physics- and spatially informed diffusion model accelerates Monte Carlo–level dose estimation for CyberKnife radiotherapy using planning CT and anatomical data.
Key Details
- 1The PSIDMViT model integrates planning CT, finite-size pencil beam dose distributions, and distance maps for dose prediction.
- 2Tested retrospectively in 251 CyberKnife patients (117 head-and-neck, 76 lung, 58 liver).
- 3Achieved 3D Gamma passing rates of 98.0% for head-and-neck, 94.0% for lung, and 95.0% for liver cases (1%/1 mm/10% criterion).
- 4Reduced dose computation time from about 1 hour to 18 minutes per plan versus Monte Carlo methods.
- 5Outperformed conventional finite-size pencil beam and baseline deep-learning models in accuracy.
- 6External and multi-institutional validation remains needed.
Why It Matters

Source
EurekAlert
Related News

AI Tool Predicts Which Rectal Cancer Patients Benefit from Intensive Therapy
UCL researchers developed an AI that analyzes biopsy slides to identify rectal cancer patients who benefit from adding irinotecan to standard chemoradiotherapy.

AI-Guided Handheld Cardiac Ultrasound Reduces Referrals and Costs in Spain
AI-guided handheld cardiac ultrasound enables primary care physicians to detect heart failure, reducing specialist referrals and saving costs.

AI-Enhanced Imaging Breaks Barriers in Complex Media for Biomedical Use
Researchers developed a physics-based machine learning imaging system that enhances visibility through complex media, holding promise for biomedical imaging.